Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Arginine-vasopressin (AVP) is known to be involved in maintaining glucose homeostasis, and AVP-resistance is observed in poorly controlled non-insulin-dependent diabetes mellitus subjects, resulting in a lowered plasma volume. Recently we reported that V1a vasopressin receptor-deficient (V1aR−/−) mice exhibited a decreased circulating blood volume and hypermetabolism of fat accompanied with impaired insulin-signaling. Here we further investigated the roles of the AVP/V1a receptor in regulating glucose homeostasis and plasma volume using V1aR−/− mice. The plasma glucose levels at the baseline or during a glucose tolerance test were higher in V1aR−/− than wild-type (WT) mice. Moreover, a hyperinsulinemic-euglycemic clamp revealed that the glucose infusion rate was significantly lower in V1aR−/− mice than in WT mice and that hepatic glucose production was higher in V1aR−/− mice than WT mice. In contrast to the increased hepatic glucose production, the liver glycogen content was decreased in the mutant mice. These results indicated that the mutant mice had impaired glucose tolerance. Furthermore, feeding V1aR−/− mice a high-fat diet accompanied by increased calorie intake resulted in significantly overt obesity in comparison with WT mice. In addition, we found that the circulating plasma volume and aldosterone level were decreased in V1aR−/− mice, although the plasma AVP level was increased. These results suggested that the effect of AVP on water recruitment was disturbed in V1aR−/− mice. Thus, we demonstrated that one of the AVP-resistance conditions resulting from deficiency of the V1a receptor leads to decreased plasma volume as well as impaired glucose homeostasis, which can progress to obesity under conditions of increased calorie intake.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice lacking the V1aR display impaired glucose tolerance, insulin resistance and elevated AVP levels20”
From Plasma Copeptin and the Risk of Diabetes Mellitus (2010) · cites this paper as [20]
In the citing paper
“The finding that mice with deleted V1aR and/or V1bR exhibit metabolic disorders [12][13][14][15] has prompted several epidemiological investigations in humans.”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [12]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660
Atrial natriuretic factor—a circulating hormone stimulated by volume loading
Lang, R. E., Thölken, H., Ganten, D., Luft, F. C., Ruskoaho, H., & Unger, T. (1985) · Nature · doi:10.1038/314264a0 · Cited by 1,230
Impact of Obesity on Plasma Natriuretic Peptide Levels
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W. F., & Vasan, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000112582.16683.ea · Cited by 1,022
Natriuretic peptides: a new lipolytic pathway in human adipocytes
Sengenès, C., Berlan, M., de Glisezinski, I., Lafontan, M., & Galitzky, J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1345 · Cited by 532
Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J. (1992) · Nature · doi:10.1038/357336a0 · Cited by 524
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Glucose Inhibition of the Glucose-sensitive Neurone in the Rat Lateral Hypothalamus
OOMURA, Y., OOYAMA, H., SUGIMORI, M., NAKAMURA, T., & YAMADA, Y. (1974) · Nature · doi:10.1038/247284a0 · Cited by 358
Kim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331
Sweeney, G., Somwar, R., Ramlal, T., Volchuk, A., Ueyama, A., & Klip, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10071 · Cited by 310
Ostrowski, N. L. (1994) · Endocrinology · doi:10.1210/en.135.4.1511 · Cited by 290
Jard, S., Gaillard, R. C., Guillon, G., Marie, J., Schoenenberg, P., Muller, A. F., Manning, M., & Sawyer, W. H. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10336-2 · Cited by 276
Tanoue, A., Ito, S., Honda, K., Oshikawa, S., Kitagawa, Y., Koshimizu, T., Mori, T., & Tsujimoto, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19656 · Cited by 258
Self-citationKalsbeek, A., La Fleur, S., Van Heijningen, C., & Buijs, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5328-03.2004 · Cited by 244
Tanoue, A., Ito, S., Honda, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419656 · Cited by 219
Self-citationInsulin signaling is required for insulin’s direct and indirect action on hepatic glucose production
Fisher, S. J., & Kahn, C. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16426 · Cited by 211
Cloning and characterization of the human V3 pituitary vasopressin receptor
de Keyzer, Y., Auzan, C., Lenne, F., Beldjord, C., Thibonnier, M., Bertagna, X., & Clauser, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01268-7 · Cited by 209
Waldhäusl, W., Kleinberger, G., Korn, A., Dudczak, R., Bratusch-Marrain, P., & Nowotny, P. (1979) · Diabetes · doi:10.2337/diab.28.6.577 · Cited by 201
Koshimizu, T.-A., Nasa, Y., Tanoue, A., Oikawa, R., Kawahara, Y., Kiyono, Y., Adachi, T., Tanaka, T., Kuwaki, T., Mori, T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600875103 · Cited by 178
Self-citationPlasma Vasopressin in Uncontrolled Diabetes Mellitus
Zerbe, R. L., Vinicor, F., & Robertson, G. L. (1979) · Diabetes · doi:10.2337/diab.28.5.503 · Cited by 158
Impairment of Insulin-mediated Glucose Metabolism by Hyperosmolality in Man
Bratusch-Marrain, P. R., & DeFronzo, R. A. (1983) · Diabetes · doi:10.2337/diab.32.11.1028 · Cited by 141
Okamoto, H., Obici, S., Accili, D., & Rossetti, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523096 · Cited by 122
Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene
Yun, J., Schöneberg, T., Liu, J., Schulz, A., Ecelbarger, C. A., Promeneur, D., Nielsen, S., Sheng, H., Grinberg, A., Deng, C.-X., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9154 · Cited by 120
Chen, D., Fucini, R. V., Olson, A. L., Hemmings, B. A., & Pessin, J. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4684 · Cited by 105
Oshikawa, S., Tanoue, A., Koshimizu, T.-A., Kitagawa, Y., & Tsujimoto, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.623 · Cited by 105
Self-citationLust, W. D., Passonneau, J. V., & Crites, S. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90712-5 · Cited by 101
Chapter 14 Molecular pharmacology and modeling of vasopressin receptors
Thibonnier, M., Coles, P., Thibonnier, A., & Shoham, M. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39016-2 · Cited by 98
Comparison of methods for calculating serum osmolality: multivariate linear regression analysis
Rasouli, M., & Kalantari, K. R. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.109 · Cited by 98
Hypermetabolism of Fat in V1a Vasopressin Receptor Knockout Mice
Hiroyama, M., Aoyagi, T., Fujiwara, Y., Birumachi, J., Shigematsu, Y., Kiwaki, K., Tasaki, R., Endo, F., & Tanoue, A. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0069 · Cited by 97
Self-citationScarpace, P. J., Matheny, M. E., Tümer, N., Cheng, K., & Zhang, Y. (2005) · Diabetologia · doi:10.1007/s00125-005-1763-x · Cited by 96
Kirk, C. J., Rodrigues, L. M., & Hems, D. A. (1979) · Biochemical Journal · doi:10.1042/bj1780493 · Cited by 94
Hermes, M. L. H. J., Ruijter, J. M., Klop, A., Buijs, R. M., & Renaud, L. P. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.2.705 · Cited by 89
Vasopressin and other agents affecting the renal conservation of water
Jackson, E. (1996) · Medical Entomology and Zoology · Cited by 86
Waldhäusl, W. K., Bratusch-Marrain, P. R., Gasic, S., Korn, A., & Nowotny, P. (1982) · Diabetologia · doi:10.1007/bf00257722 · Cited by 80
Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats
Hirasawa, A., Hashimoto, K., & Tsujimoto, G. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90226-7 · Cited by 78
Vasopressin V2-receptor-dependent regulation of AQP2 expression in Brattleboro rats
Promeneur, D., Kwon, T., Frøkiær, J., Knepper, M. A., & Nielsen, S. M. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.2.f370 · Cited by 60
Ghosh, P., Mikhailova, M., Bedolla, R. G., & Kreisberg, J. I. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.6.f972 · Cited by 56
Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells
Serradeil-Le Gal, C., Herbert, J. M., Delisee, C., Schaeffer, P., Raufaste, D., Garcia, C., Dol, F., Marty, E., Maffrand, J. P., & Le Fur, G. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.268.1.h404 · Cited by 52
Perraudin, V., Delarue, C., Lefèbvre, H., do Rego, J. L., Vaudry, H., & Kuhn, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1453 · Cited by 51
Plasma Arginine Vasopressin in diabetic ketoacidosis
Walsh, C. H., Baylis, P. H., & Malins, J. M. (1979) · Diabetologia · doi:10.1007/bf01225456 · Cited by 47
Vasopressin V1 and V2 receptors in diabetes mellitus
Trinder, D., Phillips, P. A., Stephenson, J. M., Risvanis, J., Aminian, A., Adam, W. R., Cooper, M. E., & Johnston, C. I. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e217 · Cited by 42
Kamoi, K., Ishibashi, M., & YAMAJI, T. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(05)80033-6 · Cited by 35
Inaba, K., Umeda, Y., Yamane, Y., Urakami, M., & Inada, M. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb02886.x · Cited by 35
Insulin Resistance Induced by Loop Diuretics and Hyperosmolarity in Perfused Rat Liver
Schliess, F., Dahl, S. V., & Häussinger, D. (2001) · Biological Chemistry · doi:10.1515/bc.2001.133 · Cited by 34
Hepatic glycogen metabolism in the db/db mouse
Roesler, W., Pugazhenthi, S., & Khandelwal, R. (1990) · Molecular and Cellular Biochemistry · doi:10.1007/bf00218127 · Cited by 30
Cho, K. W., Lee, S. J., Wen, J. F., Kim, S. H., Seul, K. H., & Lee, H. S. (2002) · Experimental Physiology · doi:10.1113/eph8702302 · Cited by 30
Vasopressin and blood pressure.
Thibonnier, M. (1988) · PubMed · Cited by 29
Renal resistance to vasopressin in poorly controlled type 1 diabetes mellitus
McKenna, K. Z., Morris, A. D., Ryan, M., Newton, R. W., Frier, B. M., Baylis, P. H., Saito, T., Ishikawa, S., & Thompson, C. J. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e155 · Cited by 27
Resistance to hepatic action of vasopressin in genetically obese (ob/ob) mice
HEMS, D. A., & Y, G. (1976) · Biochemical Journal · doi:10.1042/bj1600023 · Cited by 23
Plasma vasopressin during insulin withdrawal in insulin-dependent diabetes
Milles, J. J., Baylis, P. H., & Wright, A. D. (1981) · Diabetologia · doi:10.1007/bf00257428 · Cited by 16
Lack of vasopressin receptors in liver, but not in kidney, of ob/ob mice
Assimacopoulos‐Jeannet, F., Cantau, B., van de Werve, G., Jard, S., & Jeanrenaud, B. (1983) · Biochemical Journal · doi:10.1042/bj2160475 · Cited by 14
Attenuation of vasopressin-induced antidiuresis in poorly controlled type 2 diabetes
Agha, A., Smith, D., Finucane, F. M., Sherlock, M., Morris, A. D., Baylis, P. H., & Thompson, C. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00214.2004 · Cited by 14
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Vasopressin: Behavioral roles of an “original” neuropeptide
Caldwell, H. K., Lee, H.-J., Macbeth, A. H., & Young, W. S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.007 · Cited by 504
“, 2006) and impaired lipid metabolism and glucose homeostasis (Aoyagi et al., 2007; Hiroyama et al., 2007).”
BackgroundVasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
“Because V1aR-KO mice are glucose intolerant and resistant to insulin-mediated glucose uptake (26), it can be speculated that the hypermetabolism of fat is a compensatory mechanism for the reduced capacity to use glucose as an energy source.”
BackgroundMethodResultInfluentialSelf-citationPlasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299
Kohno, D., Nakata, M., Maejima, Y., Shimizu, H., Sedbazar, U., Yoshida, N., Dezaki, K., Onaka, T., Mori, M., & Yada, T. (2008) · Endocrinology · doi:10.1210/en.2007-1276 · Cited by 258
Metadata
- Authors
- Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A.
- Affiliations
- National Research Institute for Child Health and Development (JP)
- Corresponding author
- Tanoue, Akito
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-05-01
- Volume
- 148
- Issue
- 5
- Pages
- 2075-2084
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1964228140
- Semantic Scholar
- f9abd80b89e1d27908cc1c182452cb2cd575de1d
- Cited by
- 113
- References
- 53
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 11 · 2015: 9 · 2014: 5 · 2013: 2 · 2012: 6
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- vasopressin V1a receptor, vasopressin, glucose homeostasis, glucose tolerance, hepatic glucose production, liver glycogen, plasma volume, aldosterone, obesity, high-fat diet, insulin signaling, type 2 diabetes
- MeSH terms
- Animals, Arginine Vasopressin, Blood Glucose, Body Weight, Energy Intake, Dietary Fats, Feeding Behavior, Glycogen, Homeostasis, Insulin, Liver, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Obesity, Plasma Volume, Receptors, Vasopressin, Leptin, Metabolic Syndrome, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.